Personal loans have long been thought of as a last resort when unexpected costs or major life events come up. However, the rise of alternative lending has changed the way consumers think of this option.
One of the most profitable seasonal stock market trades in the past century has been the Santa Claus Rally. How can traders take advantage of the Santa Claus trade? Here’s a look at the numbers.
Unfortunately, the corporate world is filled with companies that will do whatever it takes to boost profits at the expense of the environment, the world and social progress. Self-serving and irresponsible companies may provide investors with solid returns over time. However, if you are looking for both a solid diversified investment and a way to…
One of the most common bullish technical analysis indicators is the golden cross, a signal that occurs when a short-term moving average crosses above a longer-term moving average on a stock’s chart. The golden cross indicates building bullish momentum and can be an indication of the beginning of a long-term bullish trend.
The highly-anticipated first rate hike of the Federal Reserve’s new tightening cycle finally came this month. Now that the Fed finally pulled the trigger, traders are looking for the best way to trade rising rates.
In a new report, Oppenheimer analyst Ari Wald discussed the stock market’s technical setup heading into the end of 2015. Wald also named airlines as the best-positioned group from a technical perspective.
It seems like the Macau gaming business has gotten nothing but one bad piece of bad news after another in the past year and a half. From the Chinese government corruption crackdown driving away VIP gamblers to slumping revenue numbers to a casino smoking ban to disappointing gaming table allocations at new resorts to junket embezzlement…
Star Wars: The Force Awakens has been perhaps the most hyped and anticipated movie of all-time. The movie’s opening weekend even exceeded lofty expectations, grossing $238 million for Walt Disney Co (NYSE: DIS).
Aveo Pharmaceuticals shares are surging more than 29 percent in early trading on Monday following an announcement by the company of a new partnership with EUSA Pharma granting EUSA exclusive European distribution rights for advanced renal cell carcinoma (RCC) treatment tivozanib.
In a new report, Credit Suisse analyst James Wicklund has upgraded a handful of names in the oil services industry. Wicklund believes that investors should be scooping up shares of companies with unconventional North American exposure between now and the beginning of February.